feed,title,long_url,short_url
Benzinga,Comparative Study: Workday And Industry Competitors In Software Industry,https://benzinga.com/insights/news/24/02/37314818/comparative-study-workday-and-industry-competitors-in-software-industry,https://da.gd/O4IP7
Benzinga,Insights Into Lam Research's Performance Versus Peers In Semiconductors & Semiconductor Equipment Sector,https://benzinga.com/insights/news/24/02/37314810/insights-into-lam-researchs-performance-versus-peers-in-semiconductors-amp-semiconductor-equipment-,https://da.gd/mnUjHq
Benzinga,Exploring The Competitive Space: KKR & Co Versus Industry Peers In Capital Markets,https://benzinga.com/insights/news/24/02/37314803/exploring-the-competitive-space-kkr-amp-co-versus-industry-peers-in-capital-markets,https://da.gd/ofKpW
Benzinga,Here's How Much $1000 Invested In Builders FirstSource 5 Years Ago Would Be Worth Today,https://benzinga.com/insights/news/24/02/37314798/heres-how-much-1000-invested-in-builders-firstsource-5-years-ago-would-be-worth-today,https://da.gd/1uvG
Benzinga,Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today,https://benzinga.com/insights/news/24/02/37314797/heres-how-much-100-invested-in-regeneron-pharmaceuticals-20-years-ago-would-be-worth-today,https://da.gd/PXeuP9
Benzinga,New York Attorney General Urges FDA Action On Widely Used Asthma Drug's Concerns Over Pediatric Safety,https://benzinga.com/general/biotech/24/02/37314571/new-york-attorney-general-urges-fda-action-on-widely-used-asthma-drugs-concerns-over-pediatric-sa,https://da.gd/op5C
